GP-Act III Acquisition (GPAT) EPS (Basic) (2023 - 2025)
GP-Act III Acquisition (GPAT) has disclosed EPS (Basic) for 3 consecutive years, with $0.08 as the latest value for Q4 2025.
- Quarterly EPS (Basic) fell 11.11% to $0.08 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.33 through Dec 2025, up 26.92% year-over-year, with the annual reading at $0.33 for FY2025, 2.94% down from the prior year.
- EPS (Basic) for Q4 2025 was $0.08 at GP-Act III Acquisition, down from $0.09 in the prior quarter.
- The five-year high for EPS (Basic) was $0.1 in Q3 2024, with the low at -$0.01 in Q1 2024.
- Average EPS (Basic) over 3 years is $0.05, with a median of $0.08 recorded in 2024.
- The sharpest move saw EPS (Basic) soared 101561.04% in 2024, then fell 11.11% in 2025.
- GP-Act III Acquisition's EPS (Basic) stood at -$0.0 in 2023, then soared by 4745.69% to $0.09 in 2024, then dropped by 11.11% to $0.08 in 2025.
- Per Business Quant, the three most recent readings for GPAT's EPS (Basic) are $0.08 (Q4 2025), $0.09 (Q3 2025), and $0.08 (Q2 2025).